(Q47243157)

12 January 2018

title

ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers (English)

1 reference

12 January 2018

1 reference

1 reference

9

Fergus Couch

1 reference

12 January 2018

10

Lynn C Hartmann

1 reference

12 January 2018

author name string

Camilo Adem

1

1 reference

12 January 2018

Cheryl L Soderberg

2

1 reference

12 January 2018

Kari Hafner

3

1 reference

12 January 2018

Carol Reynolds

4

1 reference

12 January 2018

Jeffrey M Slezak

5

1 reference

12 January 2018

Colleen S Sinclair

6

1 reference

12 January 2018

Thomas A Sellers

7

1 reference

12 January 2018

Daniel J Schaid

8

1 reference

12 January 2018

Robert B Jenkins

11

1 reference

12 January 2018

publication date

1 September 2004

1 reference

12 January 2018

Genes, Chromosomes and Cancer

published in

1 reference

12 January 2018

volume

41

1 reference

12 January 2018

issue

1

1 reference

12 January 2018

page(s)

1-11

1 reference

12 January 2018

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

cites work

1 reference

7 January 2021

Multistep carcinogenesis of breast cancer and tumour heterogeneity

1 reference

7 January 2021

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

1 reference

7 January 2021

Induction of multiple double-strand breaks within an hsr by meganucleaseI-SceI expression or fragile site activation leads to formation of double minutes and other chromosomal rearrangements

1 reference

7 January 2021

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

1 reference

7 January 2021

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

1 reference

7 January 2021

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

7 January 2021

Gene-Expression Profiles in Hereditary Breast Cancer

1 reference

7 January 2021

Biallelic inactivation of BRCA2 in Fanconi anemia

1 reference

7 January 2021

Analysis of the CMT1A-REP repeat: mapping crossover breakpoints in CMT1A and HNPP.

1 reference

7 January 2021

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

7 January 2021

Genetic instabilities in human cancers

1 reference

7 January 2021

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer

1 reference

7 January 2021

Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells

1 reference

7 January 2021

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

1 reference

7 January 2021

Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes

1 reference

7 January 2021

Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array

1 reference

7 January 2021

Somatic genetic alterations inBRCA2-associated and sporadic male breast cancer

1 reference

7 January 2021

c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability

1 reference

7 January 2021

Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers

1 reference

7 January 2021

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

1 reference

7 January 2021

C-myc overexpression and p53 loss cooperate to promote genomic instability

1 reference

7 January 2021

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20057

1 reference

12 January 2018

PubMed ID

15236312

1 reference

12 January 2018